跳转至内容
Merck
CN

Breath metabolite response to major upper gastrointestinal surgery.

The Journal of surgical research (2014-10-06)
Piers R Boshier, Vikash Mistry, Julia R Cushnir, Onn Min Kon, Sarah L Elkin, Sally Curtis, Nandor Marczin, George B Hanna
摘要

Esophagectomy and gastrectomy are associated with profound metabolic changes and significant postoperative morbidity. The aim of this prospective clinical study was to determine whether breath analysis can offer novel insight into the surgical metabolic response and identify biomarkers of postoperative complications, including lung injury. Breath samples were collected preoperatively and at 24, 48, 72, 96 and 168 h after esophagectomy (n = 25) and gastrectomy (n = 15). Targeted analysis of four prominent breath metabolites was performed by selected ion flow-tube mass spectrometry. Patients with nonsurgical lung injury (community-acquired pneumonia) were recruited as positive controls. Perioperative starvation and subsequent reintroduction of nutritional input were associated with significant changes in breath acetone levels. Breath acetone levels fell after esophagectomy (P = 0.008) and were significantly lower than in gastrectomy patients at postoperative time points 48 (P < 0.001) and 72 h (P < 0.001). In contrast, concentrations of isoprene increased significantly after esophagectomy (P = 0.014). Pneumonia was the most frequently observed postoperative complication (esophagectomy 36% and gastrectomy 7%). The concentration of hydrogen cyanide was significantly lower in the breath of patients who developed pneumonia, 72 h after surgery (P = 0.008). Exhaled hydrogen cyanide (P = 0.001) and isoprene (P = 0.014) were also reduced in patients with community-acquired pneumonia compared with healthy controls. Selected ion flow-tube mass spectrometry can be used as a totally noninvasive resource to monitor multiple aspects of metabolic alterations in the postoperative period. Exhaled concentrations of several prominent metabolites are significantly altered after major upper gastrointestinal surgery and in response to pneumonia.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
丙酮, ACS reagent, ≥99.5%
Sigma-Aldrich
乙酸, glacial, ACS reagent, ≥99.7%
Sigma-Aldrich
丙酮, suitable for HPLC, ≥99.9%
Sigma-Aldrich
乙酸, glacial, ReagentPlus®, ≥99%
Sigma-Aldrich
丙酮, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
丙酮, Laboratory Reagent, ≥99.5%
Sigma-Aldrich
乙酸, glacial, ≥99.99% trace metals basis
Sigma-Aldrich
乙酸 溶液, suitable for HPLC
Sigma-Aldrich
乙酸, glacial, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
乙酸, glacial, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
丙酮, suitable for HPLC, ≥99.8%
Sigma-Aldrich
丙酮, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
丙酮, ACS reagent, ≥99.5%
Supelco
丙酮, analytical standard
Sigma-Aldrich
乙酸, suitable for luminescence, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
异戊二烯, 99%, contains <1000 ppm p-tert-butylcatechol as inhibitor
USP
冰醋酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
丙酮, histological grade, ≥99.5%
USP
丙酮, United States Pharmacopeia (USP) Reference Standard
Supelco
丙酮, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
乙酸, analytical standard
Sigma-Aldrich
乙酸, ≥99.5%, FCC, FG
Sigma-Aldrich
乙酸, natural, ≥99.5%, FG
Sigma-Aldrich
丙酮, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99% (GC)
Sigma-Aldrich
乙酸, glacial, puriss., 99-100%
Sigma-Aldrich
丙酮, ≥99%, FCC, FG
Sigma-Aldrich
丙酮, natural, ≥97%
Supelco
异戊二烯, analytical standard
Millipore
Bifido 选择性添加剂 B, suitable for microbiology